Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

ClinicalTrials.gov ID: NCT03103087

Public ClinicalTrials.gov record NCT03103087. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 7:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

LIBERTY 2: An International Phase 3 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study to Evaluate Relugolix Co-Administered With and Without Low-Dose Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the benefit of relugolix 40 milligrams (mg) once a day co-administered with estradiol (E2) 1 mg and norethindrone acetate (NETA) 0.5 mg compared with placebo for 24 weeks on heavy menstrual bleeding associated with uterine fibroids.

Study identification

NCT ID
NCT03103087
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Myovant Sciences GmbH
Industry
Enrollment
382 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 50 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 14, 2017 (Actual)
Primary completion
Jul 10, 2019 (Actual)
Completion
Sep 16, 2020 (Actual)
Last update posted
Apr 20, 2022

2017 – 2020

United States locations

U.S. sites
89
U.S. states
26
U.S. cities
81
Facility City State ZIP Site status
Birmingham Birmingham Alabama 35205 —
Mesa Mesa Arizona 85209 —
Tucson Tucson Arizona 85704 —
Tuscon Tucson Arizona 85712 —
Canoga Park Canoga Park California 91303 —
Huntington Beach Huntington Beach California 92647 —
Long Beach Long Beach California 90806 —
Los Angeles Los Angeles California 90036 —
Los Angeles Los Angeles California 90057 —
Panorama Panorama City California 91402 —
San Diego San Diego California 92114 —
Upland Upland California 91786 —
Denver Denver Colorado 80209 —
Lakewood Lakewood Colorado 80228 —
Washington Washington D.C. District of Columbia 20036 —
Aventura Aventura Florida 33180 —
DeLand DeLand Florida 32720 —
Ft. Lauderdale Fort Lauderdale Florida 33316 —
Jupiter Jupiter Florida 33458 —
Lake City Lake City Florida 32055 —
Loxahachee Loxahatchee Groves Florida 33470 —
Miami Miami Florida 33126 —
Miami Miami Florida 33155 —
Miami Springs Miami Springs Florida 33166 —
New Port Richey New Port Richey Florida 34652 —
North Miami North Miami Florida 33161 —
Oviedo Oviedo Florida 32765 —
Plantation Plantation Florida 33324 —
Port St. Lucie Port Saint Lucie Florida 34952 —
Saint Cloud Saint Cloud Florida 34769 —
Sarasota Sarasota Florida 34239 —
Stuart Stuart Florida 34996 —
Tampa Tampa Florida 33606 —
Wellington Wellington Florida 33414 —
West Palm Beach West Palm Beach Florida 33409 —
Atlanta Atlanta Georgia 30312 —
Decatur Decatur Georgia 30034 —
Duluth Duluth Georgia 30097 —
Norcross Norcross Georgia 30093 —
Sandy Springs Sandy Springs Georgia 30328 —
Savannah Savannah Georgia 31406 —
Idaho Falls Idaho Falls Idaho 83404 —
Nampa Nampa Idaho 83686 —
Champaign Champaign Illinois 61820 —
Chicago Chicago Illinois 60611 —
Naperville Naperville Illinois 60540 —
Oakbrook Oak Brook Illinois 60523 —
Avon Avon Indiana 46123 —
Shawnee Shawnee Mission Kansas 66128 —
Marrero Marrero Louisiana 70072 —
Metairie Metairie Louisiana 70006 —
New Orleans New Orleans Louisiana 70115 —
Baltimore Baltimore Maryland 21208 —
Towson Towson Maryland 21204 —
Bay City Bay City Michigan 48706 —
Canton Canton Michigan 48187 —
Detroit Detroit Michigan 48201 —
Saginaw Saginaw Michigan 48604 —
Norfolk Norfolk Nebraska 68701 —
Las Vegas Las Vegas Nevada 89106 —
Las Vegas Las Vegas Nevada 89109 —
Las Vegas Las Vegas Nevada 89113 —
New Brunswick New Brunswick New Jersey 08901 —
Albuquerque Albuquerque New Mexico 87102 —
Brooklyn Brooklyn New York 11201 —
New York New York New York 10022 —
New York New York New York 10038 —
Rochester Rochester New York 14642 —
Durham Durham North Carolina 27713 —
Raleigh Raleigh North Carolina 27607 —
Winston Salem Winston-Salem North Carolina 27103 —
Cincinnati Cincinnati Ohio 45212 —
Columbus Columbus Ohio 43231 —
West Reading West Reading Pennsylvania 19611 —
Charleston Charleston South Carolina 29406 —
Beaumont Beaumont Texas 77702 —
Dallas Dallas Texas 75231 —
Dallas Dallas Texas 75234 —
Fort Worth Fort Worth Texas 76104 —
Frisco Frisco Texas 75035 —
Houston Houston Texas 77030 —
Houston Houston Texas 77054 —
Longview Longview Texas 75605 —
San Antonio San Antonio Texas 78258 —
Virginia Beach Norfolk Virginia 23502 —
Richmond Richmond Virginia 23225 —
Covington Covington Washington 98042 —
Puyallup Puyallup Washington 98372 —
Spokane Spokane Washington 99207 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03103087, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 20, 2022 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03103087 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →